Status:
UNKNOWN
Comparing Three Dimension Laparoscopic Versus Open Surgery for Perihiliar Cholangiocarcinoma
Lead Sponsor:
Tongji Hospital
Conditions:
Cholangiocarcinoma, Perihilar
Surgery
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Cholangiocarcinoma (CCA) is the most common biliary tract malignancy and the second most common primary hepatic malignancy. The prognosis of CCA is dismal. Surgery is the only potentially curative tre...
Eligibility Criteria
Inclusion
- Histologically proven pCCA.
- Highly presumed perihlar bile duct malignancy with difficulties to obtain histological evidence.
- Preoperative staging work up performed by upper abdomen enhanced CT scan.
- The subject understands the nature of this trial and willing to comply.
- Ability to provide written informed consent.
- Patients treated with curative intent in accordance to international guidelines
Exclusion
- Distant metastases: peritoneal carcinomatosis, liver metastases, distant lymph node metastases, involvement of other organs.
- Subjects undergoing any part for hepatectomy.
- Patients with high operative risk as defined by the American Society of Anesthesiologists (ASA) score \>4.
- Synchronous malignancy in other organs.
- Palliative surgery
Key Trial Info
Start Date :
March 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2022
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03383796
Start Date
March 1 2018
End Date
March 1 2022
Last Update
October 8 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Tongji Hospital
Wuhan, Hubei, China, 430000
2
Tongji Hospital
Wuhan, Hubei, China